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Abstract
Background: Expression profiling of embryonic stem (ES) cell differentiation in the presence of
serum has been performed previously. It remains unclear if transcriptional activation is dependent
on complex growth factor mixtures in serum or whether this process is intrinsic to ES cells once
the stem cell program has been inactivated. The aims of this study were to determine the
transcriptional programs associated with the stem cell state and to characterize mesoderm
differentiation between serum and serum-free culture.
Results:  ES cells were differentiated as embryoid b o d i e s  i n  1 0 %  F B S  o r  s e r u m - f r e e  m e d i a
containing BMP4 (2 ng/ml), and expression profiled using 47 K Illumina(R) Sentrix arrays. Statistical
methods were employed to define gene sets characteristic of stem cell, epiblast and primitive
streak programs. Although the initial differentiation profile was similar between the two culture
conditions, cardiac gene expression was inhibited in serum whereas blood gene expression was
enhanced. Also, expression of many members of the Kruppel-like factor (KLF) family of transcription
factors changed dramatically during the first few days of differentiation. KLF2 and KLF4 co-localized
with OCT4 in a sub-nuclear compartment of ES cells, dynamic changes in KLF-DNA binding
activities occurred upon differentiation, and strong bio-informatic evidence for direct regulation of
many stem cell genes by KLFs was found.
Conclusion: Down regulation of stem cell genes and activation of epiblast/primitive streak genes
is similar in serum and defined media, but subsequent mesoderm differentiation is strongly
influenced by the composition of the media. In addition, KLF family members are likely to be
important regulators of many stem cell genes.
Background
Embryonic stem (ES) cells isolated from the inner cell
mass of the early mammalian blastocyst-stage embryo
retain pluripotency when cultured on mouse embryonic
fibroblasts (MEFs) in the presence of leukemia inhibitory
factor (LIF) [1]. In the absence of LIF and MEF attachment,
ES cells spontaneously differentiate into multi-cellular
aggregates termed embryoid bodies (EBs). Although the
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spatial complexity of organogenesis is not established
during EB maturation, the dynamics of gene expression
closely mimic those which characterize early stages of
mouse development [2-5]. Thus, ES cell differentiation is
an excellent model system for the discovery of genes
involved in developmental processes.
Many studies have attempted to identify genes that define
the stem cell state by mining for genes co-expressed in ES
cells and various other stem cell populations such as
hematopoietic and neural stem cells [6,7], or ES cells and
trophoblast stem cells [8]. Some of these studies have
been criticized because they were unable to define a simi-
lar cohort of stem cell genes [9]. Also, this approach is
likely to find co-expression of 'housekeeping' genes that
are irrelevant to the stem cell state. More recently,
dynamic expression profiling during ES cell differentia-
tion has been undertaken using various EB culture tech-
niques [10,11] and the addition of exogenous growth
factors [7]. Most of these studies followed differentiation
for a short time period (up to 6–8 days) due to inherent
limitations of liquid or adherent cultures cell differentia-
tion systems.
Various platforms have been used to determine gene
expression profiles, including differential display, SAGE
[12] and slide micro-arrays, such as those provided by
Affymetrix, Agilent and Compugen. In this study we
employed Illumina® Sentrix Mouse-6 oligo bead arrays
[13], which have ~47 K probes that are largely based on
the MEEBO set of transcripts, plus ESTs discovered as part
of the FANTOM2 transcriptome project [14], some alter-
natively employed exons, and a small subset of non-cod-
ing transcripts. This is a new, rich and sensitive platform
for expression profiling [15].
ES cells were differentiated in methylcellulose cultures,
which allowed consistent EB development over 16 days in
either serum [2,16] or defined serum-free media contain-
ing BMP4 (2 ng/ml), termed serum-freeB4L hereafter [17].
The dynamics of loss of stem cell gene expression and acti-
vation of epiblast and primitive streak gene expression
programs were similar in serum and serum-freeB4L but QT
clustering revealed a significant difference in mesoderm
outcomes from day 6 onwards. In particular, cardiac gene
expression was greater in serum-freeB4L whereas activation
of the blood program was enhanced in serum.
High expression levels of Kruppel-like factor (KLF) family
members: Klf2, Klf4, Klf5 and Klf9 was detected in undif-
ferentiated ES cells, and confirmed by quantitative real
time RT-PCR, indirect immuno-fluorescence and DNA-
binding assays. Expression was down regulated rapidly
upon differentiation and a different set of Klfs: Klf3, Klf16
and Klf1/Eklf, were activated upon ES cell differentiation.
Also, KLF-binding sites were markedly over represented in
the proximal promoters of most stem cell specific genes,
suggesting possible direct regulation by KLFs. We suggest
a model in which the balance between self-renewal and
differentiation is regulated by competitive occupancy of
the proximal promoters of key stem cell genes such as
Zfp42/Rex-1, Nanog, Pou5f1(Oct4), Lefty1 and Lefty2, and
others such as the Klf genes themselves.
Results
Differentiation of ES cells in serum and serum-freeB4L 
culture
The directed differentiation of embryonic stem cells into
desirable cell types will depend upon the addition of spe-
cific growth factors to defined media and reproducible
physical conditions of culture. To establish a baseline for
such studies, we undertook a comparison of murine ES
cell differentiation using an embryoid body (EB) methyl-
cellulose culture system containing either 10% FBS [2] or
a chemically defined BSA-based media containing 2 ng/
ml of BMP4, termed serum-freeB4L [17]. Triplicate experi-
ments were performed in which ES cells were harvested
after feeder depletion, and set up in parallel EB cultures in
serum versus serum-freeB4L. RNA was collected at regular
intervals up to 16 days, quantitative RT-PCR was per-
formed on a panel of genes representing defined stages of
development to establish the robustness of the culture sys-
tem (Figure 1), and expression profiling was performed
using Illumina® Sentrix Mouse-6 bead arrays (see Methods
and [13]).
Changes in gene expression were extremely reproducible
across ES differentiation experiments with overall correla-
tion of global gene expression for biological replicates in
the order or 0.95–0.96. Approximately 30% of the probes
were differentially expressed at one or more stages of EB
differentiation as determined by one-way Welch ANOVA
with multiple testing corrections using the Benjamini and
Hochberg False Discovery Rate algorithm (7,967 probes
with a p-value of < 0.01 by Welch t-test) (Figure 2A).
To mine for genes with similar patterns of expression
across the time course, hierarchical clustering was per-
formed on the 7,967 probes and represented graphically.
A large percentage of these (~30%) displayed highest
expression in undifferentiated ES cells and subsequent
reduced expression over time (labeled stem in Figure 2B).
A second major cluster showed marked induction after
~day 4–6 of differentiation (labeled mesoderm in Figure
2B).
Putative stem cell genes sets
Previous studies have identified genes important to the
stem cell state by comparing expression profiling data
from different stem cell populations such as ES cells, hae-BMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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Dynamic gene expression during EB differentiation in serum and serum-free media containing BMP4 [2 ng/ml] Figure 1
Dynamic gene expression during EB differentiation in serum and serum-free media containing BMP4 [2 ng/
ml]. Expression of stem cell, primitive streak and late mesoderm genes were analysed by quantitative RT-PCR in undifferenti-
ated ES cells (0, grey bar) and in EBs collected for up to 16 days in serum (white bars) or defined media (black bars) from the 
same starting ES cell populations. Bars represent the means of three (serum) or two (serum-freeB4L) biological replicates. The 
Y-axis represents a log scale normalized relative to the housekeeping gene HPRT. Error bars indicate standard deviation.BMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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Gene expression profiles during 16 days of EB differentiation in serum and serum-free media containing BMP4 [2 ng/ml] Figure 2
Gene expression profiles during 16 days of EB differentiation in serum and serum-free media containing BMP4 
[2 ng/ml]. (A) GeneSpring representation of the subset of genes from the 48 K Illumina array that showed significant differ-
ences in gene expression at 2 or more time points. Each line represents the mean normalised expression of an individual Illu-
mina probe. Colours represent relative expression (red 4× increased; green 0.25× reduced) compared to a gene mean of 1 
(black) with expression in undifferentiated ES cells (day 0) as the decision point for colour coding. The expression profiles of T 
(brachyury), Hba (α-globin), and Igf2 are indicated for reference. (B) Clustering (tree) of the genes that showed significant (p < 
0.01) changes in gene expression upon differentiation by One-way Welch ANOVA. Expression levels are heat map colour 
coded (inset) with high expression at Day 0 coloured red and low expression coloured green.BMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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matopoietic stem cells (HSCs) and neural stem cells
[6,18]. We used two alternative approaches to identify
specific stem cell specific gene expression. Firstly, genes
with dynamic expression patterns which correlated
closely with Oct4, Sox2 or Nanog expression profiles (Pear-
son correlation > 0.9) were determined as previously
described [6,7]. Second, genes rapidly down regulated ≥3
fold by day 3 of differentiation, a time point where ES cell
clonogenicity decreases dramatically, were determined.
Not surprisingly there was very little overlap between
these gene lists, primarily because Oct4 and Nanog expres-
sion persists during EB differentiation longer than many
other stem cell genes (Figure 1). Full lists of genes ranked
according to similarity of expression (Pearson correlation
>0.9) with expression patterns for Oct4, Nanog or Sox2 are
provided in Additional files 1, 2, 3, respectively.
Only fifty-nine genes were down regulated ≥3 fold by day
3 of EB differentiation (Table 1). Many of these have been
identified as stem cell markers by other groups using alter-
native strategies [6,7,19]. Information was compiled on
their known expression patterns and/or gene knockout
phenotypes via literature searches as referenced in Table 1.
Insufficient space exists to discuss every gene and most
have been previously identified as ES cell enriched tran-
scripts. Osteopontin is secreted by osteoblasts in the bone
marrow niche where it is thought to play an important
role in the maintenance of HSC quiescence and mainte-
nance of 'stemness' [20]. It has also been discovered by
other groups as a strong marker of ES cells and is regulated
directly by the key stem cell transcription factors, Oct4
and Sox2 [21]. Thus, osteopontin is likely to be a useful
marker of ES cell pluripotency and may play autocrine or
paracrine roles in maintenance of stemness. The second
most rapidly down regulated gene was estrogen related
receptor β, Esrrb, which had previously been identified as
a stem cell specific gene and shown to be critical for main-
tenance of the stem cell state [19]. F-box 15 (Fbxo15), a
member of the large F-box family of genes [22] was also
rapidly down regulated. Fbxo15 is known to be highly
expressed in ES cells, is regulated by Oct4 and Sox2, but is
dispensable for ES cell self-renewal [23]. Recently, the
stem cell specificity of this locus was used to screen for
cDNAs capable of transforming mouse fibroblasts into ES
cell populations [24]. Other notable rapidly down regu-
lated genes included the nodal inhibitors Lefty-1 and
Lefty-2, and Zfp42/Rex-1, which are also well established
as stem cell markers [19].
Oct4, Nanog and Sox2 are not included in Table 1, even
though each is required for the maintenance of ES cell
pluripotency [25-27] due to their persistent expression
during the first 3 days of EB differentiation (Figure 1 and
5A, and Additional file 1). Indeed, Oct4  expression is
known to persist beyond the inner cell mass stage of
development in vivo, with transcripts detected in the epi-
blast and later in the primitive streak, before it becomes
further restricted to primordial germ cells [10,28]. 779
genes with a similar pattern of expression to Oct4 (Pear-
son correlation of > 0.9) were identified (Additional file
1). As expected this list also includes many well known
stem cell genes such as Sal-like 1, nodal, chromobox
homolog 7 (Cbx7), Dnmt3b and Sprouty homolog 4 [19].
We also mined for stem cell genes by looking for similar-
ity (Pearson correlation of > 0.9) with Nanog and Sox2
gene expression profiles. These provided overlapping but
not identical sets of putative stem cell specific genes
(Additional files 2, 3). Full data for the 16 days of differ-
entiation can be interrogated and mined for specific dif-
ferentiation outcomes via Signet (Login_Bruce) (see
Methods).
Tightly co-ordinated waves of gene expression suggest 
sequential activation of epiblast, primitive streak and 
mesoderm differentiation programs
Many alternative differentiation programs occur simulta-
neously during ES cell differentiation. Therefore, it is dif-
ficult to find gene syn-expression patterns that identify
specific programs using standard clustering methods. An
alternative approach is to search for expression patterns
that closely resemble genes of known function. For exam-
ple, the T box gene, brachyury, is a well characterized spe-
cific marker of the primitive streak [29]. Brachyury
expression is transient in vivo, a feature recapitulated dur-
ing ES cell differentiation [2]. Using qRT-PCR, brachyury
was induced ~1000 fold from D0 to day 4 and then rap-
idly silenced to baseline levels by D6 (Figure 1). The
dynamics of brachyury expression were similar between
serum and serum-freeB4L media (Figure 1 and 3A), but
serum-free media was unable to support brachyury induc-
tion in the absence of BMP-4 (data not shown). Thus,
BMP4 (or related factors in serum such as activin) is essen-
tial for mesoderm generation. Thirty genes were identified
with a similar expression pattern to brachyury (Pearson
correlation >0.9) (Table 2) including many genes with
established expression or critical functions during primi-
tive streak formation, such as Mix1 [30], Lim1 [31], Sp5
[32] and eomesodermin [33]. Transient expression of many
of these 'streak-specific' genes was validated by qRT-PCR
(Figure 3B and data not shown). In all cases there was a
close correlation between the qRT-PCR results and the
profiling data (Figure 3A).
Interestingly, four novel transcripts were identified in this
list (Table 2). One of these, 8430415E04Rik, was detected
by two independent probes, strongly supporting its
'streak-specific' expression; by qRT-PCR there was ~50
fold induction from day 2 to day 3 of differentiation and
a decrease to near baseline levels by day 6 (Figure 3B). The
gene contains 24 exons, and the full length cDNA encodesBMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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Table 1: Genes rapidly down regulated (>3 fold in 3 days) upon ES cell differentiation
Gene Name Synonyms Genbank ID Fold ↓ D0 → D3 Raw D0 Function Refs
Secreted phosphoprotein 1 Osteopontin; Spp1 NM_009263 26.8 3588 Reg. by Oct4 and 
Sox2
[21, 96]
Estrogen related receptor, beta Err2; Estrrb; Nr3b2 NM_011934 24.0 4238 ES cell renewal, 
placenta
[97]
F-box 15 Fbx15 NM_015798 21.8 4487 Stem cell specific 
locus
[23]
RIKEN cDNA 2200001I15 2200001I15Rik NM_183278 18.3 2780
Kruppel-like factor 2 Klf2; Lklf NM_008452 17.0 2639 Vascular defect [49]
Left-right determination, factor 
B
Leftb; Stra3; Tgfb4; Lefty 
1
NM_010094 14.4 2537 Nodal signalling 
inhibitor
[87]
Transcription factor CP2-like 1 Crtr-1; LBP-9 NM_023755 13.8 2237 ES cells, repressor [98]
Zinc finger protein 42 Rex-1; Rex1; Zfp-42 NM_009556 13.4 2108 Nanog-Sox2 
induced
[99, 100]
L-threonine dehydrogenase Tdh NM_021480 10.9 1764 L-threonine 
degradation
[101]
DNA (cytosine-5-)-
methyltransferase 3-like
D6Ertd14e, Dnmt3l NM_019448 10.8 5226 Maternal imprinting [102]
Transcription elongation factor 
A, 3
S-II, Tcea3 NM_011542 8.6 3874 ICM Expression [103]
Myosin light chain, skeletal 
muscle
MLC-2; Mlc2, Mylpf NM_016754 8.6 1560 Cardiac muscle [104]
S100 calcium binding protein A6 Cacy, S100a6, calcyclin NM_011313 8.2 9086 Cell cycle regulation [105]
Testis expressed gene 19 Tex19, 2410081M02Rik NM_028602 8.1 1963 Spermatogonia [106]
Epithelial membrane protein 1 TMP, Emp1 NM_010128 7.9 1030 Neuronal 
differentiation
[107]
DNA segment, Chr 11, ERATO 
Doi 636
D11Ertd636e NM_029794 7.9 1278 Expressed in 
Morula
[108]
Similar to solute carrier family 
7, member 3
Slc7a3 . NM_001004153 7.3 1036
Left-right determination, factor 
2
Lefta; Ebaf; Lefty 2 NM_177099 7.2 1903 Inhibitor of Nodal [109]
Junction adhesion molecule 2 Jcam2; VE-JAM, Jam2 NM_023844 6.5 713 KO normal [110]
Lysosomal-associated protein, 
transmembrane 5
E3, Laptm5 NM_010686 6.5 1539 haematopoiesis [111]
Discoidin domain receptor 1 Drr1, MCK10, EDDR1 . NM_007584 6.4 5451 Collagen response 
receptor
[112]
Aminoadipate-semialdehyde 
synthase
Aass, LKR/SDH; Lorsdh NM_013930 6.2 1094 Mitochondria [113]
RIKEN cDNA 2410039E07 2410039E07Rik NM_212483 6.2 737
RIKEN cDNA 2410004A20 2410004A20Rik NM_025890 5.7 644
Gastrulation brain homeobox 2 Gbx2, MMoxA;Stra7 NM_010262 5.6 1204 Midbrain/hindbrain 
organiser
[114]
cDNA sequence BC050188 4933403D14 NM_177742 5.6 497
Cordon-bleu Cobl, C530045F18Rik NM_172496 5.1 619
Similar to EF 1A eIF-1A, eIF-4C XM_181357 5.0 538
Regulatory factor X, 2 Rfx2 NM_009056 4.9 796 ICM expression [103]
Tissue inhibitor of 
metalloproteinase 1
Clgi;Timp;TIMP-1 NM_011593 4.6 1732 Metalloproteinase 
inhibitor matrix
[115]
Kruppel-like factor 4 Klf4, Gklf; Zie NM_010637 4.5 597 Epidermal, gut 
defect
[116]
Insulin-like growth factor 
binding protein 7
Igfbp7, Fstl2, mac25 NM_008048 4.4 813
latent transforming growth 
factor BP4
Ltbp4, 2310046A13Rik NM_175641 4.4 481
DnaJ (Hsp40) homolog, 
subfamily C, 6
Dnajc6, 2810027M23Rik NM_198412 4.3 490
Kruppel-like factor 5 Klf5, Bteb2, IKLF NM_009769 4.3 1797 Cardiovascular 
remodelling
[117]
Nuclear receptor subfamily 5, 
group A, 2
Nr5a2, Ftf;LRH-1 NM_030676 4.2 494 Ovary granulosa 
cells
[118]
RIKEN cDNA D230005D02 B230207J08 NM_172813 4.2 433
Nuclear protein 1 Nupr1, Com1;p8 NM_019738 4.1 388 KO normal [119]BMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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Intercellular adhesion molecule Icam1, CD54, Icam-1 NM_010493 4.1 716 KO normal, 
inflammation
[120]
Interleukin-1 receptor-
associated kinase 3
Irak3, IRAK-M NM_028679 3.9 409 Immune 
homeostasis
[121]
Keratin complex 1, acidic, gene 
17
Krt1-17, K17 NM_010663 3.9 368 Embryonic 
ectoderm
[122]
Stathmin-like 2 Stmn2, Scgn10, Stmb2 NM_025285 3.9 712 KO normal, cell 
cycle
[123]
Suppressor of cytokine signaling 
3
Socs3, CIS3, SSI-3 NM_007707 3.8 1081 LIF singalling [124]
Lipase, member H Lpdlr; PLA1B Liph NM_153404 3.8 446 Lipid metabolism [125]
RIKEN cDNA 4933405K07 4930427I11Rik NM_028913 3.8 573
Erythrocyte protein band 4.1-
like 4a
Epb4.1l4, NBL4 NM_013512 3.8 809 beta-catenin/Tcf 
pathway
[126]
Polo-like kinase 3 (Drosophila) 
(Plk3)
Cnk, Fnk, PRK NM_013807 3.7 567 Mitosis regulator [127]
Heat shock protein 1 (Hspb1) 27 kDa, Hsp25 NM_013560 3.7 3731 Blastocyst 
expression
[128]
RIKEN cDNA 1700061G19 1700061G19Rik XM_140052 3.7 425
Mannosidase, beta A, lysosomal Bmn, Manba NM_027288 3.7 484 Glycoprotein 
cleavage, KO 
normal
[129]
Developmental pluripotency-
associated 3
PCG7, Stella, Dppa3 NM_139218 3.6 450 Expressed in 
preimplantation 
embryos
[130]
Lysyl oxidase TSC-160, Lox NM_010728 3.6 644 KO cardiovascular 
defects
[131]
RIKEN cDNA E130014J05 Tet2 NM_145989 3.5 866
Myeloblastosis oncogene-like 2 B-myb, Mybl2 NM_008652 3.3 718 Cell proliferation 
G1/S transition
[132]
Pleckstrin homology domain 
containing, A4
PEPP1, Plekha4 NM_148927 3.3 532 Preimplantation 
embryo expression
[108]
Aurora kinase C (Aurkc) AIK3, Stk13 NM_020572 3.3 305 Chromosome 
segregation
[133]
Fibroblast growth factor binding 
protein 1
FGF-BP, Fgfbp1 NM_008009 3.1 312 Enhances FGF 
activity
[134]
Caveolin, caveolae protein 1 Cav1 NM_007616 3.1 438 KO viable, vascular 
defects
[135]
Table 1: Genes rapidly down regulated (>3 fold in 3 days) upon ES cell differentiation (Continued)
for a protein of 868 amino acids (Figure 3D) which is
highly conserved in vertebrates (Additional file 4). It has
little homology to other proteins apart from three pre-
dicted HEAT domains or armadillo domains (grey shading
in Figure 3D). Drosophila armadillo interacts with β-cat-
enin via its HEAT/armadillo repeat [34], which suggests
the protein encoded by 8430415E04Rik may also be
involved in protein-protein interactions.
The list of primitive streak genes in table 2 is smaller than
that previously published [10] due to the very stringent
criteria used to determine brachyury-like patterns of
expression. Thus, to find further genes characteristic of
epiblast, early and late primitive streak programs, probes
were identified which were transiently up and down regu-
lated at least two fold with peak expression at day 2, 3 or
4 of EB differentiation. Gene lists were combined (102
Illumina probes) and clustered into epiblast, early, mid
and late streak groups plus a unique group in which
expression was very transient at day 3 of differentiation
(designated 'brief' at the bottom of Figure 3C). Also, lists
were generated by searching for similarity of dynamic
expression profiles to known genes which are accepted
specific markers of specific stages of mouse development.
For example, Fgf5 is specifically expressed in the epiblast
[35], and Wnt5a is expressed in the late primitive streak
[36]. The Fgf5-like (epiblast) list includes the methyltrans-
ferase, Dnmt3b, which was massively up-regulated in the
first 2 days of EB differentiation (Additional file 5) and is
known to be essential for mesoderm differentiation [37].
This list also includes Pim2, Zic2, Wnt8a, the SP1 (and
possibly SP5) cofactor Crsp2, and Irf1. The Wnt5a-like
(late primitive streak) list contains 76 genes including
many homeobox genes (Hoxb2, Hoxd1, Hoxb6 and Hox8/
Msx2), Cdx2, Hand1, Tbx3, Bmp4 and the VEGF receptor
Flt1  (Additional file 6). Many are expressed at E10 of
mouse development in the remnants of the primitive
streak [36], suggesting the Wnt5a-like list includes many
genes known to pattern the embryo following formation
of the germ layers. There is a significant overlap betweenBMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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Mining for genes expressed in patterns consistent with primitive streak, and epiblast differentiation programs Figure 3
Mining for genes expressed in patterns consistent with primitive streak, and epiblast differentiation programs. 
(A) GeneSpring representation of epiblast and streak gene expression profiles during EB differentiation in 10% serum or 
serum-freeB4L culture. The up-regulation of genes between days 2–4 were similar under both conditions. (B) qRT-PCR analysis 
of Mixl, Lim1, Cdx4 and Riken clone 8430415E04Rik. The Y-axis represents expression relative to the housekeeping gene 
HPRT. Error bars indicate ± SD from three biological replicates. (C) 102 genes transiently up regulated during the first 4 days 
of ES cell differentiation were clustered using a tree algorithm and Pearson correlation of > 0.9. The 'Brief' group represents 
gene with very transient expression at day 3. (D) Coding region for 8430415E04Rik. The shaded areas represent the three 
Heat domains.BMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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Table 2: Brachyury-like (Primitive Streak) gene list (Pearson correlation >0.9 with brachyury)
Description Symbol Corr. Synonyms Genbank ID Expression/Function
Brachyury (T) T 1.00 cou;Low;Lr;;T1 NM_009309.1 [33, 136] Primitive streak
Eomesodermin * Eomes 0.98 Tbr2 NM_010136.1 [33] Primitive streak
Fibroblast growth factor 8 Fgf8 0.97 Aigf;Fgf-8 NM_010205.1 [137] primitive streak expression
Mix1 Mixl1 0.97 Mm1;Mml NM_013729.2 [30] KO primitive streak 
abnormal
Lysophospholipase isoform 1 A530050D06Rik 0.97 XM_203596
LIM homeobox protein 1 * Lhx1 0.96 Lim1; Lhx1 NM_008498 [31] Primitive streak expression
Mesoderm posterior 1 Mesp1 0.95 NM_008588.1 [138] nascent mesodermal cells
Sp5 Sp5 0.94 NM_022435.2 [32] Primitive streak expression
8430415E04Rik * 8430415E04Rik 0.94 unknown NM_028980.1
Axin2 Axin2 0.94 Axi1;Axil;Conductin NM_015732.3 [139] Wnt signalling inhibitor
Ninein Nin 0.93 mKIAA1565 NM_008697 [140] Centrosome anchoring
E330009J07Rik E330009J07Rik 0.93 mKIAA1147 NM_175528
Proteosome subunit, beta 8 * Psmb8 0.93 Lmp-7;Lmp7 NM_010724.1 [141] reduced MHC class I
Solute carrier family 30 member 3 Slc30a3 0.93 Znt3 NM_011773 [142] KO no phenotype
DHHC-type Zn-finger containing protein 2400007G07Rik 0.92 AK010296
Chemokine (C-C motif) ligand 20 Ccl20 0.92 NM_016960 [143] T and B cell regulation
Protease 28 subunit, beta * Psme2b 0.92 PA28b-p;Psme2-like NM_011191.1 [144] MHC Class I regulation
D130029J02Rik D130029J02Rik 0.92 XM_150103
F-box and leucine-rich repeat protein 14 Fbxl14 0.92 Fbx14l NM_133940
WD repeat & FYVE domain containing 1 Wdfy1 0.92 FENS-1;Jr1;WDF1 NM_027057 [145] Endosome and Golgi 
regulation
ADP-ribosylation factor-like 6 int. 
protein 2
Arl6ip2 0.92 Aip-2;AV334690 NM_019717.1
Protease 28 subunit, alpha Psme1 0.92 PA28a NM_011189.1 [146] Proteasome activator MHC 
Class I
TAF10 Taf10 0.92 30 kDa;Taf2h;TAFII30 NM_020024.3 [147] KO ICM phenotype
Helicase with zinc finger domain Helz 0.91 NM_198298 [148] Primitive streak expression
Transmembrane 4 superfamily member 
10
Tm4sf10 0.91 BCMP1 NM_175771.2
1190004M23Rik 1190004M23Rik 0.90
Carbonic anhydrase 14 Car14 0.90 NM_011797.1 [149] KO no phenotype
Male enhanced antigen 1 Mea1 0.90 Mea-1 NM_010787.1 [150] Testis development
Delta-like 3, transcript variant 1 Dll3 0.90 pu;pudgy NM_007866.1 [151] primitive streak expression
Ring finger protein 30 Rnf30 0.90 MURF;MURF-3 NM_021447.1 [152] Myogenic regulator
* More than one independent illumina probe for these genes were identified
the genes we identified as being epiblast-, early and late
streak-specific and those recently identified using a similar
EB differentiation system and Affymetrix arrays [10], and
by other groups [2,38]. In addition, there are addition
novel RIKEN cDNAs in these lists, which are likely to
encode for interesting proteins worthy of further study
(Additional files 5, 6).
Following the primitive streak wave of gene expression
there was a dramatic activation of many genes (Figure 2A).
Many of the most highly induced genes, such as globin
genes, heme synthesis enzymes and haematopoietic tran-
scription factors, are known to be expressed in the blood.
qRT-PCR for globin genes confirmed > 10,000 fold induc-
tion between days 3 and 8 with a steady decline thereafter
(Figure 1). Other mesoderm and endoderm programs are
also activated at this stage, so it is difficult to mine for
these different outcomes.
Enhanced cardiac gene expression and reduced 
erythropoiesis in serum-freeB4L EB culture
Overall there were very strong similarities between ES cell
differentiation in serum and serum-free cultures supple-
mented with 2 ng/ml BMP4. For example, all 29 of the
primitive streak gene set, as defined from serum-contain-
ing cultures, were also expressed transiently and to a sim-
ilar level in serum-freeB4L  media (Figure 3A). Genes
differentially expressed at each EB time point (Day 1–16)
were pooled and subjected to QT clustering to find sets
differentially expressed between serum and serum-freeB4L
EB culture. Using a minimal cut-off of five genes per
group, nine gene sets were identified; seven showed
higher expression in serum and two showed higher
expression in serum-freeB4L (Table 3 and Figure 4).
The genes in set 9 were expressed more highly in serum-
freeB4L media from day 6, and genes in set 8 showed up-BMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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regulation at day 12 and 16 in the absence of serum (Fig-
ure 4). Both sets are comprised almost exclusively of car-
diac-specific genes such as myosin heavy chain 7 (Myh7),
myosin light chain 7 (Myl7), the cardiac isoform of α-
actin (Actc1), troponin (Tnnc2), tropomysin (Tpm2), the
nicotinic cholinergic receptor (Chrng), and cardiac muscle
fast twitch 1 specific ATPase (Atp2a1) (Table 3). Further
interrogation of the array data revealed a cohort of cardiac
transcription factors, including ISL1, MEF2C, Bop/Smyd1
and Hand2 [39], which were transiently up regulated 1.4
to 3.5 fold in serum-freeB4L media compared to serum at
day 6 (Signet Login_Bruce). Importantly, this elevated car-
diac gene expression program correlated with increased
numbers of spontaneously beating EBs in serum-freeB4L
media (data not shown). Enhanced expression (~100
fold) of Actc1, Myl4 and Myl7 in serum-freeB4L media com-
pared with serum-containing media was confirmed by
qRT-PCR (Figure 1). Taken together, this data strongly
suggests cardiac muscle cell differentiation is either inhib-
ited in serum or enhanced by the addition of BMP4 to
serum-free culture.
The genes in set 2 were expressed in both serum and
serum-freeB4L conditions immediately following primitive
streak formation, but expressed to higher levels and
slightly earlier in serum (Table 3 and Figure 4). Many of
these genes are globins (both embryonic and definitive)
suggesting erythropoiesis is activated more robustly in the
presence of serum (See Discussion). Alas2, a gene encod-
ing the erythroid specific isoform of the first and rate lim-
iting enzyme in the heme biosynthesis pathway, and the
erythroid specific transcription factor, p45-NF-E2 are also
in set 2 [40]. qRT-PCR for α- and βh1-globin confirmed
more rapid expression in serum versus SFB4L media (Fig-
ure 1), suggesting factors in addition to BMP4 enhance
activation of the blood program from a similar primitive
streak platform.
The genes in set 3 were expressed at a similar time in
serum but expressed at very low levels or not at all in
serum-freeB4L media. Again, this set is highly enriched for
erythroid specific genes such as alpha hemoglobin stabil-
ising protein (Ahsp) [41], Glycophorin A, erythroid Krup-
pel-like factor (EKLF/Klf1) [42] and mitochondrial solute
carrier protein (mitoferrin) [43] (Figure 4 and Table 3).
Genes in sets 1 and 5 are activated more robustly at late
time points in serum cultures. Most of these are specifi-
cally expressed in macrophages. Together, these results
suggest delayed and less robust primitive haematopoiesis
occurs in SFB4L culture compared with serum, an observa-
tion confirmed by less robust erythroid cell generation
and 'redness' of the EBs from day 6–10 of differentiation
(data not shown).
Rapid changes in Kruppel-like factor gene expression upon 
ES cell differentiation
Three Kruppel-like factor genes, Klf2, Klf4 and Klf5, were
rapidly down regulated during the first few days of EB
development (bold type in Table 1). All are members of
the KLF family of transcription factors which are charac-
terized by a similar C-terminal domain of three C2H2 zinc
fingers which confers binding to CACC box elements in
promoters and more distant regulatory elements [44,45].
Klf2  and  Klf4  have N-terminal transcriptional action
domains and act primarily as transcriptional activators,
whereas Klf5 is best known as a transcriptional repressor
[46]. Until recently, Klf2 and Klf4 were considered to have
restricted expression patterns [47,48] with gene knockout
animals showing late developmental defects in vasculo-
genesis and skin differentiation, respectively [49,50].
Recently however, Klf4 expression was noted in ES cells
[19,51], and forced expression was shown to enhance
Oct4 expression and promote self-renewal [51].
qRT-PCR confirmed the rapid down regulation of Klf2,
Klf4 and Klf5 in both serum and serum-freeB4L differentia-
tion conditions, although Klf5 expression was down regu-
lated more slowly (Figure 5A and 5B, and Table 4). Klf2,
Klf4 and Klf5 were all re-induced from day 3–5 of differ-
entiation as mesoderm and endoderm developmental
pathways are activated (Figure 5A and 5B). Sixteen of the
17 known KLFs were examined in detail throughout the
entire differentiation time course (Table 4). Klf9 was also
steadily down regulated (>10 fold) between ES cells and
day 5 EBs in serum and serum-freeB4L media (Figure 5B).
Klf3, a well characterized transcriptional repressor [52] via
its ability to recruit the co-repressor, CtBP [53], displayed
an interesting biphasic expression pattern with initial
rapid down regulation then re-induction from days 5–6
(Figure 5B). In contrast, Klf16 displayed little change in
expression levels over the 16 days of EB maturation (Fig-
ure 5B).
Klf2 and Klf4 co-localize with OCT4 in the nuclei of ES
cells (Figure 6A). Interestingly, all three proteins were
found to preferentially reside in a nuclear sub-compart-
ment (possibly nucleoli for transcription factories), sug-
gesting possible co-involvement in a protein complex or
network. Also, endogenous KLF2 was detected by specific
CACC box DNA-binding activity in undifferentiated ES
cells, which was lost upon EB differentiation (Figure 6B).
In contrast, endogenous ES cell KLF4 DNA binding activ-
ity was not detected using the p18INK4c promoter CACC
box sequence, although recombinant KLF4 was shown to
bind to this probe (data not shown). SP1 and SP3 are
ubiquitously expressed CACC-box binding proteins,
which are dominant in ES cell nuclear extracts (Figure 6B).
We hypothesize KLF2, KLF3, KLF4, KLF5 and KLF6 com-
pete with SP1 family members for DNA binding to key cisBMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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Table 3: Genes differentially expressed during ES cell differentiation in serum versus serum-free defined media (BMP4 2 ng/ml)
Set 1 – Chemokine ligands (Day 8) Symbol Synonyms Genbank ID BMP4 Serum
Hydroxyprostaglandin dehydrogenase 15 Hpgd NM_008278.1 2.22 4.4
Src-like adaptor Sla Slap NM_009192 1.29 .90
Pleckstrin Plek NM_019549.1 1.31 4.9
Triggering receptor expressed on myeloid cells-like 1 Treml1 XM_128641.3 1.67 12.6
Glycoprotein 5 (platelet) Gp5 GPV NM_008148.2 1.52 8.9
2810484G07Rik 2.07 13.5
Chemokine (C-X-C motif) ligand 7 Cxcl7 b-TG1; CTAP3; LDGF; MDGF;NAP-2 NM_023785.1 1.07 4.8
Angiotensin receptor 1 Agtr1 AT1;AT1a;AT2R1 NM_177322.2 1.58 5.8
Arachidonate 12-lipoxygenase Alox12 Alox12p;P-12LO NM_007440.2 1.29 9.2
Chemokine (C-C motif) ligand 4 Ccl4 Act-2; MIP-1B NM_013652 1.81 19.5
Chemokine (C-X-C motif) ligand 4 Cxcl4 Pf4;Scyb4 NM_019932.1 3.85 29.0
ATPase, Ca2+ transporting, ubiquitous Atp2a3 Serca3 NM_016745.2 1.30 6.1
Chemokine (C-C motif) ligand 3 Ccl3 Mip1a;Scya3 NM_011337.1 1.75 11.8
Set 2 – Globins (Day 6) Symbol Synonyms Genbank ID BMP4 Serum
β-major globin Hbb-b1 AK002258 2.15 21.7
ζ-globin Hba-x NM_010405.2 4.30 128.3
ε-y globin Hbb-y E-y NM_008221.2 1.80 38.1
Nuclear factor erythroid-2 (p45) Nfe2 p45NFE2 NM_008685.2 1.32 10.4
α-globin Hba-a1 Hba1 NM_008218.1 3.21 89.7
Band-3/anion exchanger 1 Slc4a1 Ae1;CD233;Band 3 NM_011403.1 1.19 26.2
Rik2510042H12 AK011092 1.01 4.1
Aminolevulinic acid synthase 2 Alas2 Alas-2 NM_009653.1 1.14 13.2
β h1-globin Hbb-bh1 betaH1 NM_008219.2 3.65 61.2
Set 3 – Blood (Day 8) Symbol Synonyms Genbank ID BMP4 Serum
Alpha hemoglobin stabilising protein AHSP AHSP;EDRF NM_133245.1 1.7 3.4
Myeloperoxidase Mpo NM_010824 1.1 3.6
Slc38a5 SN2; JM24 NM_172479.1 1.3 2.5
Glycophorin A Gypa CD235a;GPA NM_010369.2 2.1 5.2
Cbp/p300-interacting transactivator, with Glu/Asp-
rich carboxy-terminal domain, 4
Cited4 Mrg2 NM_019563 1.3 2.5
Mitoferrin Mscp Slc25a37 NM_030054.2 1.5 2.4
Kruppel-like factor 1 Klf1 Eklf NM_010635 1.8 3.6
Set 4 – Various (Day 16) Symbol Synonyms Genbank ID BMP4 Serum
FXYD domain-containing ion transport regulator 2 Fxyd2 Atp1g1 NM_007503 1.38 6.7
Thioether S-methyltransferase Temt NM_009349 0.97 6.0
Mus musculus FXYD domain-containing ion transport 
regulator 2, transcript variant a
Fxyd2 Atp1g1 NM_052824.1 1.16 5.7
Fibrinogen, alpha Fga Fib NM_010196.1 2.06 11.8
Kininogen-1 Kng1 NM_023125.2 6.25 37.3
Serum amyloid A 3 Saa3 Saa-3 NM_011315 1.04 4.5
Deleted in azoospermia-like Dazl Dazla;Tpx-2;Tpx2 NM_010021.2 0.91 3.8
Fibrinogen, alpha Fga Fib NM_010196.1 2.57 14.3
Chitinase 3-like 1 Chi3l1 brp-39;Brp39;Gp39 NM_007695.1 1.75 7.3
Kininogen II NM_201375.1 1.73 7.9
Set 5 – Macrophage (Day 16) Symbol Synonyms Genbank ID BMP4 Serum
Neutrophil cytosolic factor 2 Ncf2 Ncf-2; p67phox NM_010877 2.05 3.56
Complement component 1q beta C1qb NM_009777.1 1.13 4.63
Matrix metalloproteinase 12 Mmp12 Mmel NM_008605.1 3.17 8.53
Complement component 3 C3 ASP;Plp NM_009778.1 2.17 10.46
CD68 antigen Cd68 gp110;Scard1 NM_009853 1.84 5.58BMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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Macrophage expressed gene 1 Mpeg1 XM_129176 3.08 6.74
TYRO protein tyrosine kinase binding protein Tyrobp DAP12;KARAP;Ly83 NM_011662.2 2.80 4.81
Myosin IF Myo1f NM_053214.1 1.64 3.33
Hematopoietic protein 1 Hemp1 NM_153505.2 1.41 4.22
Glutathione S-transferase, alpha 3 Gsta3 Gst2-3 NM_010356.2 1.73 8.67
Glycoprotein (transmembrane) nmb Gpnmb Dchil;ipd NM_053110 1.55 6.63
Pleckstrin homology, Sec7 and coiled/coil domains 4 Pscd4 2510004M07Rik NM_028195 1.54 3.83
B-cell leukaemia/lymphoma-2 related protein A1b Bcl2a1b A1-b NM_007534 2.49 6.35
Complement component 1q, gamma C1qg C1qc NM_007574.1 1.26 5.27
Fc receptor, IgG, low affinity III Fcgr3 CD16 NM_010188.2 2.10 5.84
Lysozyme Lyzs Lys;Lzm;;Lzp NM_017372.2 5.80 21.72
Chemokine (C-C motif) ligand 9 Ccl9 CCF18;MRP-2; NM_011338 2.26 3.85
B-cell leukemia 2 related protein A1d Bcl2a1d A1-d NM_007536 2.51 4.49
EGF-like module containing, mucin-like, hormone 
receptor-like 1
Emr1 F4/80; Ly71;TM7LN3 NM_010130.1 1.54 3.44
Set 6 – Day 16 Symobol Synonyms Genebank ID BMP4 Serum
Insulin-like growth factor 1 Igf1 C730016P09Rik;Igf-1;Igf-I NM_010512.2 1.6 4.8
Prss35 NM_178738.1 4.7 5.9
Protein tyrosine phosphatase, non-receptor type 
substrate 1
Ptpns1 CD172a; SHP-1;SHPS-1; XM_149178.1 2.2 3.7
Apolipoprotein A-II Apoa2 Alp-2;Apoa-2;ApoA-II;Hdl-1 NM_013474.1 9.8 57.4
Spondin 2, extracellular matrix protein Spon2 ;M-spondin;Mindin NM_133903.2 2.0 12.0
Set 7 – Stem and late Day 16 Symbol Synonyms Genbank ID BMP4 Serum
Fbox 15 Fbxo15 0.96 4.4
Aurora kinase C Aurkc AIE1;AIK3;Stk13 NM_020572.1 0.94 4.1
2200001I15Rik NM_183278.1 0.94 6.4
Hypothetical protein LOC236546 AF067061 NM_199060.1 0.85 3.8
Eukaryotic translation initiation factor 1A LOC195150 XM_111306.1 0.80 9.3
Similar to Pro-Pol-dUTPase polyprotein; RNaseH LOC386244 XM_359136.1 0.88 5.2
Similar to hypothetical protein FLJ35105 LOC245109 XM_142517.3 0.89 3.7
Down regulated in renal cell carcinoma Drr1 TU3A AK044219 0.57 9.3
Set 8 – Cardiac Day 16 Symbol Synonyms Genbank ID BMP4 Serum
ATPase, Ca++ transporting, cardiac muscle, fast twitch 
1
Atp2a1 SERCA1 NM_007504.2 6.9 1.1
Cholinergic receptor, nicotinic, gamma Chrng Achr-3;Acrg NM_009604.2 4.5 1.0
Myosin, light polypeptide 1 BC059087.1 8.0 1.1
Alpha actin, skeletal muscle Acta1 Acta-2;Acts;Actsk-1 NM_009606.1 25.3 1.2
Tropomyosin 2 beta Tpm2 Tpm-2;Trop-2 NM_009416.2 11.6 1.3
Cholinergic receptor, nicotinic, alpha Chrna1 Achr-1;Acra NM_007389.2 4.1 1.0
Troponin C2, fast Tnnc2 Tncs NM_009394.2 5.7 0.9
Neurofilament 3, medium Nef3 NF-M;NF160;Nfm NM_008691.1 4.5 1.1
Myosin heavy chain Myh8 XM_354617 6.7 1.1
Cholinergic receptor, nicotinic, alpha 1 Chrna1 Achr-1;Acra NM_007389.2 5.4 1.1
Set 9 – Cardiac 2 Day 6 Symbol Synonyms Genbank ID BMP4 Serum
a-Actin, cardiac Actc1 Actc-1 NM_009608.1 31.2 3.6
Somatostatin Sst Smst;SOM;SRIF;SS NM_009215.1 10.8 2.2
Myosin, light polypeptide 7, regulatory Myl7 MLC2a;MYL2A;;RLC-A NM_022879.1 14.3 4.7
Myosin, heavy polypeptide 7, cardiac muscle, beta Myh7 Myhc-b;Myhcb NM_080728.1 8.2 2.4
a-Actin, cardiac Actc1 Actc-1 NM_009608.1 26.3 3.5
Table 3: Genes differentially expressed during ES cell differentiation in serum versus serum-free defined media (BMP4 2 ng/ml) BMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
Page 13 of 26
(page number not for citation purposes)
QT clustering revealed sets of genes differentially expressed between serum and serum-freeB4L EB culture Figure 4
QT clustering revealed sets of genes differentially expressed between serum and serum-freeB4L EB culture. QT 
clustering revealed nine sets of genes with similar dynamic expression profiles (Pearson Correlation coefficient of > 0.9). In 
sets 1–7, expression is higher in serum (black sets). In sets 8–9, expression is greater in serum-freeB4L EB culture (red sets). 
Some sets have been named based on the similarity of overall gene function during differentiation pathways (see Table 3).BMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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elements in various stem cell genes to regulate expression
in positive and negative fashions (see Discussion).
Enrichment of KLF-binding cis elements in the proximal 
promoters of stem cell specific genes
To investigate whether Kruppel-like factors might directly
regulate stem cell gene expression, and therefore play a
role in the maintenance or loss of 'stemness', the presence
of KLF transcription factor binding sites (TFBS) within the
proximal promoters of all genes in Table 1 was deter-
mined. Although a position weighted matrix (PWM) for
KLF4 binding site specificity has been published [54], this
site does not resemble the CACC box sequences known to
bind other KLFs. Since KLF4 has identical DNA-binding
residues in each of its three C-terminal C2H2 zinc fingers
to other members of the Kruppel-like factor family [45], it
should bind to similar sequences. Based on the crystal
structure of the zinc fingers of Zif268 and SP1 bound to
DNA [55,56], and testing of specific binding of CACC box
variants to recombinant KLF1, KLF3 and KLF17
[45,52,57,58], a generic KLF TFBS has been proposed.
Although a SELEX experiment for KLF1 binding has not
been published, experiments from our group suggest a C
at position 1, an A or C at position 3, an A at position 5,
and an A, T or C at position 9 of the 9 bp consensus pro-
vides enhanced affinity for KLF1 binding. Taken together,
these studies have enabled the development of a PWM
(called here KLF-A) that should predict KLF4, KLF2 and
other KLF TFBSs (see Methods and Additional file 7).
Clover [59] was used to determine if defined TFBSs were
statistically over-represented in the stem cell lists. We
searched for PWMs for KLF-A, KLF4 [54], octamer,
extended octamer, nanog, and Oct-Sox binary sites as well
as negative control sites (gata-1 and E-box) in sequences 2
kb upstream of the TSSs of stem cell genes (Table 1), ver-
sus 2 kb of sequences upstream of the entire murine tran-
scriptome (See Additional file 7 for details of PWMs).
There was significant over-representation of KLF-A TFBS
within the first 2 kb of promoter sequences from the stem
list gene list (p value of < 0.01) (Figure 7A), as well as
over-representation of octamer sites and extended Oct4-
binding sites as defined from ChIP-PET data [60]. No sta-
tistically significant over-representation of KLF4 [54],
NANOG, GATA1 or E-box TFBSs were identified. All genes
in the rapidly down regulated gene list have at least one
KLF-A type CACC site, or octamer or Oct4 [60] TFBS. A
full list of the promoters with highlighted sites is available
on request. Together, this data strongly suggests direct
transcriptional regulation of many stem cell genes by
KLFs.
The Zfp42/Rex1 gene promoter is presented as an example
of output from the Clover program (Figure 7B). It con-
tains five KLF-A, one octamer and three OCT4 TFBS. The
two CACC box elements within the first 250 base pairs of
the TSS represent classical extended KLF-binding sites
[42,61]. These regions are the same as previously reported
[62] although their functional importance has not been
determined. Interestingly, two of the three KLF-A TFBS
were evolutionarily conserved between the mouse and rat
gene promoters (Figure 7C). Also, two further conserved
CACC sites at -1.4 and -1.5 kb were identified within 500
bp of extended evolutionary conservation (>70% iden-
tity) (Figure 7C). This might act as a KLF dependent
enhancer. Most of the stem cell genes in list 1 have con-
served CACC box elements in their promoters [63-66]. In
some cases these have been reported to bind the ubiqui-
tous SP1, but our Clover analysis suggests they are also
likely to bind KLFs (see Discussion).
Discussion
Expression profiling of murine ES cell differentiation was
undertaken over a 16-day time course. We compared gene
expression in methylcellulose cultures containing serum
versus chemically defined media containing LIF (1 U/ml)
and low concentrations of BMP4 (2 ng/ml) [67]. The Illu-
mina® Sentrix Mouse 6 bead array provided a sensitive and
detailed platform for analysis of dynamic gene expression.
Using various data mining approaches, lists of stem cell-
enriched genes and genes that are induced during the in
vitro equivalent of epiblast and primitive streak stages of
differentiation were generated. In combination with other
ES cell profiling studies [7], our detailed expression data
provides a useful resource for future reverse genetic
approaches (i.e. siRNA knockdown) to study the function
of these genes during ES cell differentiation and in vivo
development. We also found a number of previously
uncharacterized cDNAs (RIKEN clones) which could play
important roles during development.
Importantly, the loss of pluripotency, measured by Oct4
gene expression, was comparable between serum and
serum-freeB4L EB culture, following a predicted decrease
over the first 6 days. Surprisingly, Oct4 gene expression
gradually increased following day 6, an observation inde-
pendent of the cell lines used (data not shown). It remains
undetermined if expansion of Oct4 positive ES cells per-
sists as undifferentiated populations within our EB culture
system. Previous studies have identified the development
of Oct4 positive primordial germ cells (PGC) following
12 days of ES cell differentiation [68-70], suggesting the
Oct4 profile may alternatively represent the expansion of
non-ES cell populations. Although the expansion of some
undifferentiated ES cells is possible, the array profile does
not suggest global persistence or up-regulation of ES gene
expression late in the EB program. Also, markers of meso-
derm induction such as brachyury and Mixl, do not show
persistent up-regulation following peak expression at day
4, suggesting EBs are unlikely to harbour cells which areBMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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Table 4: Kruppel-like factor gene expression during ES cell differentiation
Symbol Synonyms Genbank ID Illumina® Probe ID Absolute Expression Level
ES Cell EB (Day)
Serum-free 10% Serum
Day 0 3 6 3 6
Klf1 Eklf NM_010635 scl33570.4.1_25-S 110 105 125 114 2138
Klf2a Lklf NM_008452 scl016598.3_26-S 2275 269 157 272 248
Klf3b Bklf;Tef-2 AK046659
NM_008453
ri|B430304G02| 3393-S 112 92 80 102 99
scl0016599.2_295-S 894 406 733 374 881
scl27779.8_253-S 638 182 422 251 442
Klf4a Gklf; Zie NM_010637 scl0016600.2_155-S 149 85 86 104 102
scl0016600.2_249-S 575 89 109 112 127
scl016600.7_29-S 101 69 64 86 83
Klf5a Bteb2;IKLF NM_009769 scl0012224.2_233-S 1981 699 232 699 274
scl45215.1.1_294-S 79 91 83 112 105
scl46026.3_338-S 183 91 78 112 99
Klf6 BCD1;CPBP;Klf6;Zf9 NM_011803 scl023849.4_8-S 1107 1697 1540 1996 1457
scl45096.3_115-S 177 251 221 307 232
Klf7 9830124P08Rik AK086122;
NM_033563
ri|D930007C01| 2481-S 319 243 207 270 227
scl0093691.2_69-S 334 281 202 345 231
scl16685.5_486-S 439 398 305 440 309
Klf8 Klf8 NM_173780 scl0245671.1_6-S 136 113 116 139 120
Klf9a BTEB-1;Klf9 NM_010638 scl53274.2_128-S 2035 910 205 1120 394
Klf10 Tieg1; Egra; Tieg NM_013692
AK043433
scl47275.9_20-S 84 83 70 96 92
ri|A730095A08| 2144-S 71 65 64 93 81
Klf11 Tieg3; Tieg2b; FKLF NM_178357 scl0194655.4_70-S 71 68 67 86 78
Klf12 AP-2rep;B130052C06Rik NM_010636 scl000297.1_3-S 75 70 70 104 93
scl0016597.1_0-S 79 81 70 104 93
scl016597.1_75-S 92 102 86 122 121
scl45206.9.1_30-S 79 81 85 101 92
scl45212.1.365_19-S 62 61 56 75 73
Klf13 Bteb3;FKLF2; RFLAT-1 NM_021366 scl31250.6.4_21-S 291 284 245 332 308
Klf14 1110025J03Rik;Epfn;Klf14 NM_031183 scl0083395.1_307-S 109 141 103 168 140
scl13960.1.1_83-S 167 193 166 237 183
scl13961.1.1_105-S 83 75 73 104 87
Klf15 1810013I09Rik;CKLF;KKLF NM_023184 scl29751.3_94-S 118 125 101 156 120
Klf16a BTEB4;DRRF NM_078477 scl37728.2_209-S 355 181 177 249 167
a. Enriched in undifferentiated ES cells
b. Biphasic expression pattern (See Figure 5)
delayed or arrested from entering the differentiation pro-
gram.
We found significant differences in cardiac gene expres-
sion during EB differentiation in serum and serum-freeB4L
culture. Our current understanding of cardiac develop-
ment provides possible insights into this observation.
Briefly, in vivo studies have revealed BMPs secreted from
the anterior lateral plate, and ill-defined signals from
anterior primitive endoderm, are key inducers of cardiac
development [71-73]. The administration of recombinant
BMP2 or BMP4 to chick explant cultures induces cardiac
differentiation in non-cardiogenic mesoderm [71] and
Bmp2  knockout animals develop cardiac abnormalities
[74]. Conversely, Wnts secreted by the neural tube are
strong suppressors of cardiogenesis. Together, these
opposing signals act to establish the borders of the heart
field [71,75]. By mimicking the environment that estab-
lishes cardiogenesis in vivo, assays capable of directing car-
diomyocyte production from ES cells have been
established. BMPs can efficiently enhance the cardiac pro-
gram when added to EB culture [76,77], whereas BMP
inhibition drastically suppresses this outcome. In our
hands cultures supplemented with BMP4 (2 ng/ml) sup-BMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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ported cardiomyocyte maturation (as determined by
expression of cardiac specific genes) with greatest expres-
sion detected at Day 8–10. This correlated with increased
numbers of spontaneously beating EBs, and the timing of
initial spontaneous contractions during murine embryo-
genesis [78]. The cardiac program was significantly
reduced in culture containing 10% serum, an observation
supported by a number of other studies [79,80]. This sug-
gests the constituents of serum are inhibitory to cardiomy-
ocyte development. Although a detailed assessment of
cardiomyocyte differentiation was not the focus of this
analysis, the array output, qRT-PCR profiles and morpho-
logical observations described supports the usefulness of
this assay in future investigations. In addition, the defined
constituents of serum-freeB4L media provides an excellent
opportunity to identify additional recombinant factors
required to further expand cardiac progenitor cell produc-
tion from EBs.
In contrast, the hematopoietic program was more pro-
nounced within EBs grown in 10% serum than BMP4
alone (Figure 1 and 4). In particular, EKLF (Klf1) expres-
sion was significantly reduced in serum-free media sup-
plemented with BMP4 (2 ng/ml) compared with serum
(Figure 5A and Table 4). EKLF is essential for regulation of
a large cohort of erythroid specific genes [81,82], many of
which were identified in sets 2 and 3 (Figure 4). Thus, it is
likely that reduced EKLF expression in SFB4L media directly
results in inhibition of a cascade of erythroid gene expres-
sion. Previous work showed the addition of BMP (at 5 ng/
ml) to serum-free ES cell culture induces EKLF expression
and restores hematopoietic cell differentiation [83].
Although a weak hematopoietic program was observed in
SFB4L culture, the concentration of BMP4 used was less
than that used by Adelman et al. Thus, we suggest a robust
cardiac (anterior-ventral mesoderm) gene expression pro-
gram is induced by low conentrations of BMP4 (or other
BMPs), whereas a robust blood gene expression program
(posterior-ventral mesoderm) requires >2 ng/ml of BMP4
or additional growth factors. Recently, mesoderm derived
progenitor cell populations for hematopoietic and cardiac
lineages were studied during EB development using ES
cells in which GFP is targeted to the brachyury locus [80].
Within day 3.25 EBs, GFP+Flk1+ cells were shown to rep-
resent hematopoietic precursors, whereas GFP+Flk1- cells
were significantly enriched for cardiac progenitor popula-
tions. It would be interesting to determine if the ratio of
Flk1+/Flk1- within the brachyury positive population is
altered between our two culture conditions.
A number of the Kruppel-like factor family of transcrip-
tion factors were dynamically expressed in the first few
days of ES cell differentiation. It was initially surprising to
find highly enriched Klf2 and Klf4 expression in ES cells,
since both are considered markers of terminally differen-
tiated cell types such as skin [50], gut [84], vascular
smooth muscle [49,85] and lymphocytes [86]. However,
recent evidence suggests KLFs may regulate stem cell func-
tion, since Klf4 is enriched in ES cells [19] and forced over-
expression within these cells can maintain pluripotency in
the absence of LIF [51]. Furthermore, Klf4 can bind the
Lefty1 gene core promoter co-operatively with Oct4 and
Sox2 [65]. Although Lefty 1 and 2 are best characterized as
repressors of nodal, acting to regulate left-right patterning
[87], our results and those of others, suggest a possible
redundant role for lefty proteins during the maintenance
of ES cell pluripotency [65]. Similarly to the Oct4 expres-
sion profile, many of the KLF family members also
increased in expression late in the differentiation pro-
gram. As mentioned, the KLFs are expressed in diverse tis-
sues during development. It is therefore expected that the
profiles obtained reflect the generation and early specifi-
cation of mesoderm and endoderm cells following primi-
tive streak gene activation at day 4.
Based on the likely identical binding specificity of the KLF
family, established transcriptional activation and repres-
sion roles of certain family members [44], and bioinfor-
matic evidence of a high prevalence of KLF TFBSs in many
stem cell genes, we propose KLF competition for occu-
pancy of these CACC box elements might determine self-
renewal versus differentiation of ES cells. According to this
model, high levels of KLF2 and KLF4 expression in undif-
ferentiated ES cells would lead to occupancy of CACC box
elements in promoters of stem cell genes such as Pou5f1/
Oct4, Nanog, Esrrb, Zfp42/Rex1, Lefty1 and Lefty2. Further-
more, the Klf2 and Klf4 genes themselves have CACC box
elements in their proximal promoters (Figure 7A), sug-
gesting a positive feedback loop within ES cells is likely.
Interestingly, gene knockout and lentiviral shRNA gene
knockdown of Klf2 or Klf4, does not lead to an obvious
stem cell defect [19,49,50,85], suggesting these two KLFs
may have functionally redundant roles during the mainte-
nance of pluripotency. Future analysis of KLF2/KLF4 dou-
ble knockout ES lines or the knockdown of both proteins
using RNAi technologies will be necessary to validate this
hypothesis. Upon ES cell differentiation, down regulation
of Klf2 and Klf4 was very rapid, whereas down regulation
of Oct4 and Nanog was delayed for one to two days. We
suggest loss of KLF2 and KLF4 binding to Pouf1/Oct4,
Nanog, Esrrb and perhaps other stem cell promoters, could
be directly responsible for their down regulation. Moreo-
ver, Klf5 was down regulated more slowly, and Klf3 was
up-regulated in the first two days of differentiation, sug-
gesting these KLFs may function primarily as transcrip-
tional repressors at the Pouf1/Oct4, nanog, Zfp42 and Esrrb
gene promoters. Once this differentiation driving tran-
scription network is activated we suggest KLF3, KLF5 and
KLF9 can accelerate loss of the stem cell state by directly
repressing expression of the Klf2 and Klf4 genes them-BMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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Kruppel like factors (Klfs) are dynamically expressed during the first few days of ES cell differentiation Figure 5
Kruppel like factors (Klfs) are dynamically expressed during the first few days of ES cell differentiation. (A) 
GeneSpring plot of normalized gene expression for all KLFs detected during ES cell differentiation in serum or serum-freeB4L 
culture. Most of the genes are listed on the y-axis in order from their highest relative expression in ES cells. There is dramatic 
up regulation of Klf1 (Eklf) only in serum following day 6 of differentiation. Plots representing Nanog (red), Sox2 (red) and 
Pou5f1(Oct4) (green) are shown for comparison. Pou5f1 and Nanog gene expression persists at high levels for 2–3 days after 
Klf2, Klf4 and Klf5 are down regulated. (B) Validation of changes in gene expression of six members of the KLF family by quan-
titative real time RT-PCR. Scheme as described for Figure 2B.BMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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Kruppel like factor expression and DNA binding activity during ES cell differentiation Figure 6
Kruppel like factor expression and DNA binding activity during ES cell differentiation. (A) Co-expression of Oct4 
with KLF2 or KLF4 in ES cells. Indirect immuno-fluorescence shows co-localization of KLF2 and KLF4 with Oct4 in sub-nuclear 
compartments (possibly nucleoli). Individual confocal images for OCT4, KLF2, KLF4, and DAPI are shown with the corre-
sponding composite image. Scale bar 40 μm. (B) Electro-mobility gel shift assay showing changes in DNA binding activities at a 
conserved CACC box site in the p18-INK4c gene promoter. Nuclear extracts were generated from ES cells or EBs differenti-
ated for four days in serum. Super-shifts were performed with specific antisera for SP1, SP3, KLF2, KLF3, and KLF4 (See Meth-
ods). There is strong binding of endogenous Sp1 to the CACC element in ES cells and EB cells. KLF2 DNA-binding activity is 
present in ES cells as determined by a specific inhibition of binding of the indicated DNA complex with a KLF2 antibody. This 
activity is lost upon differentiation into EBs. The identity of the CACC box binding activity in EBs denoted CAC-X, and the 
binding activity in ES cells denoted CAC-Y, was not definitively identified using this panel of antibodies.BMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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KLF and octamer binding sites are highly enriched in stem cell gene promoters Figure 7
KLF and octamer binding sites are highly enriched in stem cell gene promoters. (A) A Clover analysis was used to 
identify over-represented transcription factor binding sites within the promoter sequences of all stem cell genes identified in 
Table 1. Representative gene promoters are shown, indicating KLF-A binding sites (pink), octamer sites (ATGCWAAT) 
(green) and extended Oct4 binding sites (Oct4-Loh)(cyan) [60]. (B) Clover output for 2 kb of promoter sequence of murine 
Zfp42/Rex1. The positions and sequences corresponding to PWMs for KLF-A, octamer and Oct4 occupancy sites are indicated 
in the table and colour coded in the sequence. The positions are relative to the transcriptional start site. (C) ECR Browser 
output of conserved sequence identity between mouse and rat in the promoter and part of the first intron of the Zfp42 gene. 
The blue arrows indicate the direction of transcription. Yellow indicates the extent of the first (non-coding) exon, pink indi-
cates regions of sequence conservation in the first intron and red indicates regions of sequence conservation in the 5' 
upstream region. rVISTA was used to find all of the KLF-A and octamer sites in the murine gene (Murine only) and conserved 
sites between mouse and rat (Conserved mouse, rat).BMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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selves. Therefore, a combination of cross regulation of
transcriptional outputs, and competition for occupancy of
key stem cell promoters by KLF proteins with differing
biochemical properties but identical DNA-binding capac-
ities, may determine self-renewal versus differentiation
outcomes. Again validation of this model requires func-
tional analysis. It is important to note we have not proven
occupancy of stem cell gene promoters by the KLFs in vivo.
Chromatin immuno-precipitation (ChIP) experiments in
ES cells and differentiated populations are essential to val-
idate this model, however ChiP grade antibodies are not
currently available.
This scenario is not necessarily limited to ES cell differen-
tiation. A similar program may take place in many adult
stem and progenitor cells populations. Certainly competi-
tion between Klf4 and Klf5 has been suggested to regulate
cell growth [88], and Klf1 and Klf3 compete for binding
and have opposing effects in blood cells [89]. Further-
more, an imbalance between occupancy of key stem cell
or proliferation gene promoters by KLFs, with differing
activating and repressing functions, could be responsible
for the development or progression of many common
forms of cancer. For example, loss of hetero-zygosity for
Klf4 and Klf5 has been found in colon, stomach, breast,
prostate and liver cancers [90,91].
In addition to the proposed complex transcriptional inter-
play between KLFs and stem cell gene promoters, direct
protein-protein interactions and protein networks involv-
ing KLFs are possible. We showed sub-nuclear localization
of KLF2 and KLF4 with OCT4 in ES cells (Figure 6A), and
KLF4 can co-operate with OCT4 and SOX2 to drive expres-
sion of the Lefty1 core promoter [65]. Also, very recent
biochemical purification of NANOG-interacting proteins
discovered KLF4 as part of a NANOG-OCT4 network in ES
cells (Stuart Orkin, personal communication). This is also
consistent with the ability of KLF4 to co-operate with
OCT4, SOX2 and c-MYC to drive de-differentiation of
fibroblasts into ES-like cells [24].
Conclusion
Defining the genetic regulation of ES cell self renewal and
differentiation will be instrumental for the development
of future cell based therapies. Using 47 K Illumina® Sentrix
bead arrays, the differential expression of genes during 16
days of ES cell differentiation was determined. Hierarchi-
cal gene clustering and correlation statistical analyses lead
to the identification of a small cohort of genes which
define the stem cell state. Historically, ES cell differentia-
tion is achieved in culture media containing 10–15% FBS.
A direct comparison between ES cell differentiation in
serum and a serum-free media was undertaken. Surpris-
ingly, global gene expression profiles were comparable
between culture conditions, with the exception of meso-
derm derived cardiac and haematopoietic transcripts.
These results support the use of defined serum-free
approaches for the directed differentiation of ES cell com-
mitment. Expression of many KLF family members were
enriched in ES cells and rapidly down regulated upon dif-
ferentiation. KLF2 and KLF4 were co-localisation with
OCT4 in ES cell nuclei and KLF transcription factor bind-
ing sites were over-represented within the promoters of
the putative ES cell gene list (p < 0.01). Taken together,
this data strongly suggests KLF family members regulate
the maintenance of ES cell pluripotency.
Methods
ES cell culture, embryoid body formation and 
immunohistochemistry
W9.5 ES cell differentiation was performed as described
(Bruce et al., Differentiation, in press). For immuno-fluo-
rescence, feeder depleted W9.5 ES cells were seeded onto
sterile gelatin-coated glass cover slips in ES cell media,
fixed in 4% PFA for 10 min then washed in PBS. Cover
slips were boiled in 10 mM citric acid (pH 6.4) for 10 min,
washed in PBS and permeabilized in 0.18% triton X-100
in PBS for 10 mins. For OCT4/KLF4 detection, the cover
slips were blocked in 1% BSA then incubated with rabbit
polyclonal antibody raised against OCT4 (Abcam
#ab19857) and goat Anti-mouse KLF4 (R&D Systems
#AF3158) overnight at 4°C, then incubated in goat anti-
rabbit Alexa-488 (1:400) (Molecular Probes #A11008)
and donkey anti-goat Alexa-647 (1:400) for 1 hour. For
co-detection of OCT4/KLF2, the Zenon Rabbit IgG label-
ling kit was used (Molecular Probes #Z-25308). 1 μg of
KLF2 rabbit polyclonal antibody (Santa Cruz SC-28675)
was labeled with Alexa647 Fab fragment following the
manufacturer's instructions. Cover slips already stained
for OCT4 (Alexa488) were incubated with labeled KLF2
for 1 hr then washed and post-fixed in 4% PFA to ensure
strong signal detection. DAPI 1:5000 (Molecular Probes
#D3571) was used to detect nuclear localization. Cover
slips were mounted on SuperFrost® Plus slides (Menzel-
Glaser) with VectaShield mounting media (Vector Labora-
tories H-1000). Confocal microscopy was performed on
LSM 510 META Carl Zeiss microscope system.
RNA extraction, cDNA synthesis and real-time RT-PCR 
data analysis
Total RNA was made using TRIzol (Invitrogen), and
cDNA was synthesized from 2 μg of DNase1-treated total
RNA using Superscript III (Invitrogen) and oligo-DT12–15
(Promega) according to the manufacturer's instructions.
Quantitative RT-PCR (qRT-PCR) was carried out using the
Applied Biosystems SYBR-green dye system and 7500 Real
Time Cycler in 96-well plates. Cycling variables were as
follows: 50°C for 2 minutes, 95°C for 10 minutes, then
40 cycles of 15-second denaturation at 95°C and 1-
minute at appropriate annealing temperatures, optimizedBMC Genomics 2007, 8:365 http://www.biomedcentral.com/1471-2164/8/365
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for each set of primers based on dissociation curves (Addi-
tional file 8). Expression levels were normalized to HPRT
as determined from the ratio of delta CT values. Mean of
relative expression ± SD was determined from three bio-
logical replicates. Sequencing of gel-purified amplicons
was performed to ensure correct product amplification.
Micro-array hybridization and analysis
Expression profiling was performed using Sentrix Mouse-
6 Expression BeadChip arrays from Illumina®. RNA was
assessed for integrity using the Agilent Bioanalyzer 2100
and RNA integrity (RIN) scores above 9.5 were present in
all samples. Amplification was performed with 500 ng of
total RNA using the Illumina TotalPrep RNA Amplifica-
tion kit (Ambion) with a 12 hour in vitro transcription
reaction period. The quantity and quality of biotin-UTP
incorporated cRNA was also assessed on the Agilent Bio-
analyzer 2100. Amplified cRNA (1500 ng per array) was
hybridized to Mouse-6.v1 BeadChip arrays according to
the manufacturer guidelines and detected with Fluorolink
Streptavidin-Cy3 (Amersham Biosciences). Arrays were
scanned using the Illumina BeadStation Scanner. The raw
intensity values obtained for the scanned array images
were compiled using the proprietary BeadStudio v1.5.1.3
software and imported into GeneSpring GX v7.3.1 (Agi-
lent). A mouse Illumina probe set was defined in the
GeneSpring Workgroup using the Illumina targetIDs as
the unique identifiers and annotated according to array
content files supplied by illumina®. Data normalization
was performed by first setting all measurements less than
0.01 to 0.01, then applying per chip normalization to the
50th  percentile, and per gene normalization to the
median.
From an interpretation which included the three FBS
experiments, a non-parametric Welch ANOVA (where var-
iances were not assumed equal) was performed on all
46,120 probes to find a subset of genes whose expression
varied significantly throughout the differentiation time
course. A Benjamini and Hochberg False Discovery Rate
multiple testing correction was applied to reduce the
number of false positives. This yielded a set of 7,967
probes that showed statistically significant (p < 0.05) dif-
ferences in expression by Welch t-test. This approach sim-
plified running the data mining algorithms to find syn-
expression patterns by removing genes such as housekeep-
ing genes which did not display differential expression, or
genes which did not reach a threshold of expression at any
time points.
Genome interpretations were generated in GeneSpring
GXv7.3.1 (Agilent) in which the mean relative expression
level for each gene was represented at each time point rel-
ative to the average of all time points. A number of statis-
tical approaches were used to find syn-expression
patterns. A Pearson correlation (between 0.9 and 1.0) was
performed to find genes with similar expression profiles
to Pouf1/Oct4, nanog, sox2, fgf5, wnt5 and brachyury. Hier-
archical clustering was performed using the gene by gene
and group by group 'tree' algorithm within the Gene-
Spring (Agilent) program. This compares each probe with
every other in the lists to generate similarity statistics and
a tree representation of similarity based on a Pearson cor-
relation. Also, quality threshold (QT) clustering [92] was
used to define distinct subsets of co-expressed genes. The
entire data set for the experiments is available via GEO as
well as via our instance of Genespring (contact corre-
sponding author).
Electro-mobility gel shift assays (EMSA)
Nuclear extracts were made from undifferentiated ES cells
and embryoid bodies grown for four days in 10% serum.
Electromobility gel shift assays (EMSA) were performed as
previously described [61] using double stranded oligonu-
cleotide probes corresponding to an extended CACC site
in the p18INK4c promoter (sense strand 5'-gttgggcg-
gggcgtgggcggggcc-3') (Tallack, et al., submitted). Super-
shifts were performed with specific antibodies raised
against SP1 (Santa Cruz SC-059x), SP3 (Santa Cruz SC-
644x), KLF2 (Santa Cruz SC-28675), KLF3 [52] and KLF4
(Santa Cruz SC-12538x).
Bioinformatic searches for CACC sites and other over 
represented elements in promoters of stem cell genes
The data-mining tool Biomart (accessed via Ensembl
release 36 of the mouse genome), was used to collate 2 kb
of sequences upstream of the transcriptional start sites
(TSSs) of all genes listed in Table 1. The Clover program,
run via the MotifViz web interface [59], was used to search
for over-representation of position weighted matrices
(PWMs) for octamer [93], Oct4 [60], Oct-Sox [60], KLF4
[54], E-box, GATA-1 [94] and CACC (KLF-A) elements in
these promoter sets. The PWMs are listed in Additional
file 7. The ECR Browser [95] was used to determine phyl-
ogenetic conservation of cis elements between mouse, rat
and human genomes.
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